GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » EV-to-EBIT

PanGenomic Health (XCNQ:NARA) EV-to-EBIT : -0.12 (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PanGenomic Health's Enterprise Value is C$1.45 Mil. PanGenomic Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$-11.76 Mil. Therefore, PanGenomic Health's EV-to-EBIT for today is -0.12.

The historical rank and industry rank for PanGenomic Health's EV-to-EBIT or its related term are showing as below:

XCNQ:NARA' s EV-to-EBIT Range Over the Past 10 Years
Min: -19.01   Med: 0   Max: 0
Current: -0.12

XCNQ:NARA's EV-to-EBIT is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 17.505 vs XCNQ:NARA: -0.12

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PanGenomic Health's Enterprise Value for the quarter that ended in Sep. 2023 was C$4.59 Mil. PanGenomic Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$-11.76 Mil. PanGenomic Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -256.35%.


PanGenomic Health EV-to-EBIT Historical Data

The historical data trend for PanGenomic Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health EV-to-EBIT Chart

PanGenomic Health Annual Data
Trend Dec21 Dec22
EV-to-EBIT
- -2.13

PanGenomic Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.85 -2.13 -0.74 -0.40 -0.39

Competitive Comparison of PanGenomic Health's EV-to-EBIT

For the Health Information Services subindustry, PanGenomic Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PanGenomic Health's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PanGenomic Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PanGenomic Health's EV-to-EBIT falls into.



PanGenomic Health EV-to-EBIT Calculation

PanGenomic Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1.454/-11.759
=-0.12

PanGenomic Health's current Enterprise Value is C$1.45 Mil.
PanGenomic Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PanGenomic Health  (XCNQ:NARA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PanGenomic Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-11.759/4.587128
=-256.35 %

PanGenomic Health's Enterprise Value for the quarter that ended in Sep. 2023 was C$4.59 Mil.
PanGenomic Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PanGenomic Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


PanGenomic Health (XCNQ:NARA) Business Description

Traded in Other Exchanges
Address
3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.
Executives
Kaidong Zhang Senior Officer

PanGenomic Health (XCNQ:NARA) Headlines

No Headlines